Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Tax Assets Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Sanara MedTech (SMTI) Current Deferred Revenue (2017 - 2018)

Sanara MedTech (SMTI) has disclosed Current Deferred Revenue for 2 consecutive years, with $10474.0 as the latest value for Q4 2018.

For the quarter ending Q4 2018, Current Deferred Revenue fell 24.76% year-over-year to $10474.0, compared with a TTM value of $10474.0 through Dec 2018, down 24.76%, and an annual FY2018 reading of $10474.0, down 24.76% over the prior year.
Current Deferred Revenue was $10474.0 for Q4 2018 at Sanara MedTech, down from $12141.0 in the prior quarter.
Across five years, Current Deferred Revenue topped out at $13920.0 in Q4 2017 and bottomed at $10474.0 in Q4 2018.